| Announce Date | 11/12/2025 |
| EPS Normalized Actual | $-1.18 (Miss by $-0.53) |
| EPS GAAP Actual | $-1.18 (Miss by $-0.53) |
| Revenue Actual | $0.0122B |
| Revenue Surprise | Beat by $12.2M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-1.22 |
| EPS GAAP Estimate | $-1.22 |
| Revenue Estimate | $0.0225B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | -4.08 | -0.48 | -4.26829 | -3.89171 | 1 |
| Dec 2026 | -1.69 | -1.16 | -1.96898 | -1.41102 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -1.18 | -0.08 | 0.0122B | 16.05% | -12.8M |
| FQ2 2025 (Jun 2025) | -1.08 | 2.0638 | 0.012103B | 21.98% | -29.04M |
| FQ1 2025 (Mar 2025) | -4.32 | -0.91324 | 0.011605B | 27.76% | -23.53M |
| FQ4 2024 (Dec 2024) | 0 | 2.26 | 0.01007B | 31.82% | -5.48M |
| FQ3 2024 (Sep 2024) | -4.01 | -1.69 | 0.010242B | 100% | -0.91M |
| FQ2 2024 (Jun 2024) | -3 | -4.34259 | 0.009443B | 100% | -2.47M |
| FQ1 2020 (Mar 2020) | 0 | 0 | 0B | NAN% | 0M |
| FQ2 2020 (Jun 2020) | 0 | 0 | 0B | NAN% | 0M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-1.22
Consensus Revenue Estimates
0.0225B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.94 | -- | -0.94 | -0.94 | 1 |
| FQ3 2026 (Sep 2026) | -1.03 | -14.56 | -1.03 | -1.03 | 1 |
| FQ2 2026 (Jun 2026) | -1.09 | 0.92 | -1.09 | -1.09 | 1 |
| FQ1 2026 (Mar 2026) | -1.22 | -254.1 | -1.22 | -1.22 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.03B | -- | 0.03B | 0.03B | 1 |
| FQ3 2026 (Sep 2026) | 0.03B | 51.2 | 0.03B | 0.03B | 1 |
| FQ2 2026 (Jun 2026) | 0.03B | 51.59 | 0.03B | 0.03B | 1 |
| FQ1 2026 (Mar 2026) | 0.02B | 48.42 | 0.02B | 0.02B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
4
EPS # of in-lines
2
Revenue # of Beats
0
Revenue # of Misses
6
Revenue # of in-lines
2
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -1.1 | -1.18 | -0.08 | 6.78% |
| FQ2 2025 (Jun 2025) | -3.1438 | -1.08 | 2.0638 | -191.09% |
| FQ1 2025 (Mar 2025) | -3.40676 | -4.32 | -0.91324 | 21.14% |
| FQ4 2024 (Dec 2024) | -2.26 | 0 | 2.26 | INF% |
| FQ3 2024 (Sep 2024) | -2.32 | -4.01 | -1.69 | 42.14% |
| FQ2 2024 (Jun 2024) | 1.34259 | -3 | -4.34259 | 144.75% |
| FQ1 2020 (Mar 2020) | 0 | 0 | NAN% | |
| FQ2 2020 (Jun 2020) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.03B | $0.01B | $-12.8M | -104.92% |
| FQ2 2025 (Jun 2025) | $0.04B | $0.01B | $-29.04M | -239.98% |
| FQ1 2025 (Mar 2025) | $0.04B | $0.01B | $-23.53M | -202.8% |
| FQ4 2024 (Dec 2024) | $0.02B | $0.01B | $-5.48M | -54.42% |
| FQ3 2024 (Sep 2024) | $0.01B | $0.01B | $-0.91M | -8.87% |
| FQ2 2024 (Jun 2024) | $0.01B | $0.01B | $-2.47M | -26.2% |
| FQ1 2020 (Mar 2020) | $0B | $0B | $0M | NAN% |
| FQ2 2020 (Jun 2020) | $0B | $0B | $0M | NAN% |